The natural history of classic galactosemia: lessons from the GalNet registry

M E Rubio-Gozalbo,M Haskovic,A M Bosch,B Burnyte,A I Coelho,D Cassiman,M L Couce,C Dawson,D Demirbas,T Derks,F Eyskens,M T Forga,S Grunewald,J Häberle,M Hochuli,A Hubert,H H Huidekoper,P Janeiro,J Kotzka,I Knerr,P Labrune,Y E Landau,J G Langendonk,D Möslinger,D Müller-Wieland,E Murphy,K Õunap,D Ramadza,I A Rivera,S Scholl-Buergi,K M Stepien,A Thijs,C Tran,R Vara,G Visser,R Vos,M de Vries,S E Waisbren,M M Welsink-Karssies,S B Wortmann,M Gautschi,E P Treacy,G T Berry

DOI: https://doi.org/10.1186/s13023-019-1047-z

2019-04-27

Abstract:Background: Classic galactosemia is a rare inborn error of carbohydrate metabolism, caused by a severe deficiency of the enzyme galactose-1-phosphate uridylyltransferase (GALT). A galactose-restricted diet has proven to be very effective to treat the neonatal life-threatening manifestations and has been the cornerstone of treatment for this severe disease. However, burdensome complications occur despite a lifelong diet. For rare diseases, a patient disease specific registry is fundamental to monitor the lifespan pathology and to evaluate the safety and efficacy of potential therapies. In 2014, the international Galactosemias Network (GalNet) developed a web-based patient registry for this disease, the GalNet Registry. The aim was to delineate the natural history of classic galactosemia based on a large dataset of patients. Methods: Observational data derived from 15 countries and 32 centers including 509 patients were acquired between December 2014 and July 2018. Results: Most affected patients experienced neonatal manifestations (79.8%) and despite following a diet developed brain impairments (85.0%), primary ovarian insufficiency (79.7%) and a diminished bone mineral density (26.5%). Newborn screening, age at onset of dietary treatment, strictness of the galactose-restricted diet, p.Gln188Arg mutation and GALT enzyme activity influenced the clinical picture. Detection by newborn screening and commencement of diet in the first week of life were associated with a more favorable outcome. A homozygous p.Gln188Arg mutation, GALT enzyme activity of ≤ 1% and strict galactose restriction were associated with a less favorable outcome. Conclusion: This study describes the natural history of classic galactosemia based on the hitherto largest data set.